HNHamideh Najafi

Hamideh Najafi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hamideh Najafi has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Aida Goudarzi

    Department of Clinical Science, Faculty of Veterinary Medicine, Science and Research Branch, Islamic Azad University, Tehran, Iran

    1 shared publication
  • Arash Ghalyanchilangeroudi

    Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran

    1 shared publication
  • Arash Ghalyanchilangeroudi

    Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran

    1 shared publication
  • Arezoo Fallah

    Department of Bacteriology and Virology, Faculty of Medicine, Isfahan University of Medical sciences, Isfahan, Iran

    1 shared publication
  • Hooman Rahmati-Holasoo

    Department of Aquatic Animal Health, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran

    1 shared publication
  • Iman Pouladi

    Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran

    1 shared publication

Latest Publications

  • Open Access

    Molecular characterization and phylogenetic analysis of Cyprinid herpesvirus 3 genotypes in Iran from 2020 to 2023

    by Zahra Ziafati Kafi, Arash Ghalyanchi Langeroudi, Mojtaba Alishahi, Hooman Rahmati-Holasoo, Sara Shokrpoor, Hamideh Najafi

    The aquaculture industry in Iran contributed to about 1% of the world’s aquaculture production in 2020 with a volume of 0.7 million tons. A targeted approach was used to identify positive samples by collecting samples from 342 suspected carp farms showing signs of disease. The carp species was considered as the host for the viruses under investigation and Khuzestan, Mazandaran and Gilan provinces were selected for sampling. A total of 251 farms in Gilan, 68 farms in Mazandaran, and 23 farms in Khuzestan provinces were sampled. Cyprinid herpesvirus 3 (CyHV-3) was characterized by a combination of sequence analysis and duplex PCR. Genetic analyzes and phylogenetic tree construction were performed using MEGA7 software. Of the 342 farms sampled, 85 were infected with koi herpes virus (KHV). Asian 1 and Asian 2 genotypes were identified by sequence analysis of the SphI-5 and TK gene regions. One of the positive samples showed a match in all motif positions within the TK gene, specifically genotype A1, except for positions 814 − 813 where they had the sequence AT, which was a rare exception. Duplex PCR analysis of two variable marker regions between ORF29 and ORF30 (marker I) and ORF133 and its upstream region (marker II) revealed viruses of genotype J (I++ II +), an intermediate genotype (I++ II -), and a new genotype, I++ II -*, identified in viruses from different farms. This new genotype retains the I++ allele of marker I and has a 5-bp deletion in the marker II. The global distribution of CyHV-3 genotypes is not yet fully elucidated. Results indicate the high degree of diversification of CyHV-3 in the West Asian regions, where at least three different genotypes (I++ II +, I++ II -, and I++ II -Δ) currently appear to circulate.


  • Top Cited Papers
    Open Access

    Dengue virus: Etiology, epidemiology, pathobiology, and developments in diagnosis and control – A comprehensive review

    by Masoud Pourzangiabadi, Hamideh Najafi, Arezoo Fallah, Aida Goudarzi, Iman Pouladi


  • Vaccine approaches and treatment aspects against Crimean Congo hemorrhagic fever

    by Soroush Sarmadi, Arash Ghalyanchilangeroudi, Hamideh Najafi

    Crimean-Congo hemorrhagic fever [CCHF] is a severe infectious viral disease caused by a tick borne virus which can lead to fatal hemorrhagic disease in humans. It has been reported from some continents including Africa, Asia and Europe. Virus is transmitted to human mainly through tick bite, whose acquire infection from reservoirs wild and domesticated mammalians and ostriches. Currently no approved vaccine or drug is available for CCHF and prevention is mainly based on biosecurity measures. Ribavirin is the only approved drug that has been used in some countries to treat human disease, however some new studies did not prove the Ribavirin efficacy. Different strategies to design effective vaccines, have been conducted through years, from inactivated virus to nucleotide-based ones including DNA and mRNA vaccines. In this study we review of pioneering vaccine candidate platforms.